Overview

Letrozole and Misoprostol for Termination of Pregnancy up to 63 Days' Gestation

Status:
Recruiting
Trial end date:
2022-02-28
Target enrollment:
Participant gender:
Summary
Study to determine if a user-friendly medical abortion regimen using letrozole and misoprostol is safe and acceptable.
Phase:
Phase 2
Details
Lead Sponsor:
Gynuity Health Projects
Treatments:
Letrozole
Misoprostol